A humanitarian aid convoy provided by the Saqr bin Mohammed Al Qasimi Foundation for Charity and Humanitarian Work entered the Gaza Strip under Operation Chivalrous Knight 3, carrying a shipment of therapeutic and preventive supplies designated for children and women.
Seoul [South Korea], December 26: ABL Bio (CEO Sang Hoon Lee), a company specializing in bispecific antibodies, announced that ABL Bio will receive a USD 40 million upfront payment for the license, research and collaboration agreement for its Grabody platform, and a USD 15 million equity inv
The UAE's health sector recorded a series of landmark achievements in 2025, reinforcing the country's position as a global hub for medical innovation and enhancing the readiness of its healthcare system across diagnostic, therapeutic, and research domains.
The report mentioned that India's pharmaceutical industry is entering a decisive new phase marked by tighter supply chains, sustainable manufacturing pressures and an accelerated global shift toward advanced biologics.
Singapore, November 26: Prestige Biopharma, a biopharmaceutical company specializing in antibody therapeutics, today announced an exclusive license and supply agreement with Biosidus, a biotechnology company headquartered in Buenos Aires, Argentina, with decades of experience in biosimilar d
San Francisco [US], November 19: In a defining chapter for global cardiovascular care, MedAlliance, the Swiss-based innovator behind the patented SELUTION Sirolimus Drug-Eluting Balloon (DEB), continues to transform the landscape of heart disease treatment following its acquisition by Cordis
Mumbai (Maharashtra) [India], November 12: Lupin Digital Health, India's leading cardiac digital-therapeutics company, today announced the launch of VITALYFE™, an AI-powered cardiometabolic wellness platform designed to help India's working professionals reclaim their heart health. Built on
Mumbai (Maharashtra) [India], November 11: Cordis, a global leader in interventional cardiovascular technology, announced the groundbreaking results from the SELUTION DeNovo and SELUTION4ISR trials at Transcatheter Cardiovascular Therapeutics® (TCT®) 2025, the annual scientific symposium of
Hyderabad (Telangana) [India], November 10: The Continental Next-Generation Biobank was inaugurated at Continental Hospitals, Gachibowli, Hyderabad on November 10th, 2025. The Biobank is designed to accelerate AI-powered biomedical discovery and therapeutic development globally.
Nucelion Therapeutics Pvt Ltd, a newly established Hyderabad-based Contract Research, Development, and Manufacturing Organisation (CRDMO) focused on cell and gene therapies, announced its formal launch on Monday.
New Delhi [India], October 30: Few fragrances can transport you through time the way Mysore Sandalwood does. The aroma of this legendary wood is not just a scent -- it's a feeling, a memory, and a symbol of India's timeless luxury. Known globally as "Liquid Gold" and revered as the "Fragrant
Mumbai (Maharashtra) [India], October 24: ProlyteORS, the flagship brand of Cipla Health Limited, welcomes the recent directive from the Food Safety and Standards Authority of India (FSSAI), which mandates the removal of the term 'ORS' from food and beverage product names, labels, and tra